Genstar Closes Maiden Investment from New Fund, Backs PSKW
October 09, 2015
Marking the first deal from its Fund VII, Genstar Capital has announced a substantial investment in PSKW, a provider of patient prescription medication assistance solutions and payment reimbursement services for the pharmaceutical industry. PSKW partners with over 300 pharmaceutical brands to drive medication loyalty, compliance and adherence. Genstar Capital Partners VII closed earlier this year on $2.1 billion.